Leading the Way in Life Science Technologies

GEN Exclusives

More »

GEN Contributor

Courtenay C. Brinckerhoff

<p> Courtenay C. Brinckerhoff (<a href="mailto:[email protected]">[email protected]</a>) is a partner, chair of IP Law &amp; Practice, and member of the Chemical, Biotechnology &amp; Pharmaceutical practice of Foley &amp; Lardner.</p>

More GEN Content From This Contributor:

GEN Articles

More GEN Content From This Contributor:

Insight & Intelligence™

Be sure to take the GEN Poll

Drug Price Hikes

Novum Pharma recently raised the price of an acne cream by over 3,900% in less than a year-and-a-half and Mylan increased price of EpiPen from $100 to $608 . Do you think pharmaceutical companies need to be subjected to price controls?

More »